The study found that PET microplastics may contribute to chronic lung diseases like IPF by inducing "oxidative stress, ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...

BECHTELSVILLE, Pennsylvania (WPVI) -- Most of us take breathing for granted. But with pulmonary fibrosis, patients lose that despite the best medical efforts. That outcome is on the verge of change.

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

The florist passed away after being diagnosed with pulmonary fibrosis – a condition that causes lung tissue damage.

Dear Dr. Roach: My mother is 86 years old. She is in relatively good health. She recently saw her primary care physician for her routine checkup. Prior to her visit, she had developed cold symptoms.

Esbriet (pirfenidone) is a brand-name drug prescribed for adults with a lung condition called idiopathic pulmonary fibrosis. As with other drugs, Esbriet can cause side effects, including nausea, ...

Modulator therapy does not appear to affect the magnitude of lung function impairment or recovery pattern during pulmonary ...

Appeal for organ donors after patient dies while awaiting double lung transplant The family of a florist who died from a lung ...

Kay Robertson died aged 57 while waiting for a life-saving double lung transplant after being diagnosed with pulmonary ...

CLEVELAND, Ohio — Many patients with advanced cystic fibrosis — an illness that causes thick mucus secretions — turn to lung transplants to improve their quality of life. But in taking that step, they ...